Is an intravenous histamine H2 receptor antagonist superior to an intravenous proton pump inhibitor in acid suppression?
Kinoshita
Yoshikazu
Y
Ishihara
Shunji
S
D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015738:Famotidine / Q000008:administration & dosage / Q000627:therapeutic use; D005744:Gastric Acid / Q000378:metabolism*; D006635:Histamine H2 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D009853:Omeprazole / Q000008:administration & dosage / Q000627:therapeutic use; D054328:Proton Pump Inhibitors
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D015738:Famotidine; D009853:Omeprazole